1Agarwal SK, Judd HL. Estrogen replacement therapy and breast cancer. Fertil Steril, 1999, 71: 602-603.
2Santen RJ, Petroni GR. Relative versus attributable risk of breast cancer from estrogen replacement therapy. J Clin Endocrinol Metab,1999,84:1875-1881.
3Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med, 1995, 332: 1589-1593.
4Collaborative group on hormonal factors in breast cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiologic studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet, 1997,350:1047-1059.
5Magnusson C, Baron JA, Correia N, et al . Breast-cancer risk following long-term oestrogen and oestrogen-progestin-replacement therapy. Int J Cancer,1999, 81:339-344.
6Sitruk-Ware R. Progestins in the menopause. J Steroid Biochem Mol Biol, 1999, 69: 185-193.
7Persson I, Weiderpass E, Bergstrom R, et al. Risk of breast and endometrial cancer after estrogen and estrogen-progestin replacement therapy .Cancer Causes Control,1999,10:253-260.
8Schairer C, Lubin J, Troisi R, et al. Menopausal estrogen and estrogen -progestin replacement therapy and breast cancer risk.JAMA, 2000,283:485-491.
9Ross PK, Paganini-Hill A, Wan PC, et al.Effect of hormone replacement therapy and breast cancer risk:estrogen versus estrogen plus progestin. JNCI, 2000,92:328-332.
10Lange C A, Richer JK, Horwitz KB.Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol, 1999,13:829-836.
5Jung Ki Kim , Alley D, Hu PF, et al. Changes in postmenopausal hormone therapy use since 1988. Women's Health Issues, 2007,17:338-341.
6Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science, 2005, 308 : 1583-1587.
7Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. The New England Journal of Medicine ,2007,356:2591-2602.
8Maclennan A, Lester S, Moore V. Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review. Climacteric, 2001,4: 58-74.
9Brown JS, Vittinghoff E, Kanaya AM, et al. Urinary tract infections in postmenopausal women : effect of homone therapy and risk factors. Obstet Gynecol , 2001,98 : 1045-1052.
10Warren MP. Historical perspectives in postmenopausal hormone therapy: defining the right dose and duration. Mayo Clin Proc, 2007,82:219-226.
